These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 27935072

  • 1. Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study.
    Westerberg E, Molin CJ, Lindblad I, Emtner M, Punga AR.
    Muscle Nerve; 2017 Aug; 56(2):207-214. PubMed ID: 27935072
    [Abstract] [Full Text] [Related]

  • 2. The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study.
    Westerberg E, Molin CJ, Spörndly Nees S, Widenfalk J, Punga AR.
    Medicine (Baltimore); 2018 Aug; 97(31):e11510. PubMed ID: 30075515
    [Abstract] [Full Text] [Related]

  • 3. Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training.
    Rahbek MA, Mikkelsen EE, Overgaard K, Vinge L, Andersen H, Dalgas U.
    Muscle Nerve; 2017 Oct; 56(4):700-709. PubMed ID: 28085204
    [Abstract] [Full Text] [Related]

  • 4. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?
    Lucia A, Maté-Muñoz JL, Pérez M, Foster C, Gutiérrez-Rivas E, Arenas J.
    Muscle Nerve; 2007 Jan; 35(1):125-8. PubMed ID: 16967472
    [Abstract] [Full Text] [Related]

  • 5. Physical training and exercise in myasthenia gravis.
    Gilhus NE.
    Neuromuscul Disord; 2021 Mar; 31(3):169-173. PubMed ID: 33461846
    [Abstract] [Full Text] [Related]

  • 6. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 7. Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis.
    Yan C, Song J, Pang S, Yi F, Xi J, Zhou L, Ding D, Wang W, Qiao K, Zhao C.
    J Clin Neurosci; 2018 Feb; 48():238-242. PubMed ID: 29239825
    [Abstract] [Full Text] [Related]

  • 8. Compound Motor Action Potential: Electrophysiological Marker for Muscle Training.
    Molin CJ, Punga AR.
    J Clin Neurophysiol; 2016 Aug; 33(4):340-5. PubMed ID: 26744834
    [Abstract] [Full Text] [Related]

  • 9. Effects of napping on neuromuscular fatigue in myasthenia gravis.
    Kassardjian CD, Murray BJ, Kokokyi S, Jewell D, Barnett C, Bril V, Katzberg HD.
    Muscle Nerve; 2013 Nov; 48(5):816-8. PubMed ID: 23836427
    [Abstract] [Full Text] [Related]

  • 10. Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.
    Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR.
    J Neuroimmunol; 2018 Aug 15; 321():164-170. PubMed ID: 29804819
    [Abstract] [Full Text] [Related]

  • 11. Physical training effects in myasthenia gravis.
    Lohi EL, Lindberg C, Andersen O.
    Arch Phys Med Rehabil; 1993 Nov 15; 74(11):1178-80. PubMed ID: 8239958
    [Abstract] [Full Text] [Related]

  • 12. Neuromuscular blocking activity in the blood of patients with myasthenia gravis.
    Parkes JD, McKinna JA.
    Lancet; 1966 Feb 19; 1(7434):388-91. PubMed ID: 4159777
    [No Abstract] [Full Text] [Related]

  • 13. Heavy-resistance exercise-induced increases in jump performance are not explained by changes in neuromuscular function.
    Thomas K, Toward A, West DJ, Howatson G, Goodall S.
    Scand J Med Sci Sports; 2017 Jan 19; 27(1):35-44. PubMed ID: 26639349
    [Abstract] [Full Text] [Related]

  • 14. Changes in Physical Fitness and Body Composition Associated with Physical Exercise in Patients with Myasthenia Gravis: A Longitudinal Prospective Study.
    Chang CC, Chen YK, Chiu HC, Yeh JH.
    J Clin Med; 2021 Sep 06; 10(17):. PubMed ID: 34501479
    [Abstract] [Full Text] [Related]

  • 15. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.
    Punga AR, Andersson M, Alimohammadi M, Punga T.
    J Neurol Sci; 2015 Sep 15; 356(1-2):90-6. PubMed ID: 26095457
    [Abstract] [Full Text] [Related]

  • 16. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR, Flink R, Askmark H, Stålberg EV.
    Muscle Nerve; 2006 Jul 15; 34(1):111-5. PubMed ID: 16453324
    [Abstract] [Full Text] [Related]

  • 17. Early effect of tacrolimus in improving excitation-contraction coupling in myasthenia gravis.
    Imai T, Tsuda E, Hozuki T, Yamauchi R, Saitoh M, Hisahara S, Yoshikawa H, Motomura M, Kawamata J, Shimohama S.
    Clin Neurophysiol; 2012 Sep 15; 123(9):1886-90. PubMed ID: 22386321
    [Abstract] [Full Text] [Related]

  • 18. Myasthenia gravis: evidence for a "central" defect.
    McComas AJ, Sica RE, Brown JC.
    J Neurol Sci; 1971 May 15; 13(1):107-13. PubMed ID: 5566107
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
    Hoffmann S, Siedler J, Brandt AU, Piper SK, Kohler S, Sass C, Paul F, Reilmann R, Meisel A.
    BMC Neurol; 2015 Dec 23; 15():265. PubMed ID: 26701600
    [Abstract] [Full Text] [Related]

  • 20. Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission.
    Namba T, Grob D.
    Neurology; 1969 Feb 23; 19(2):173-84. PubMed ID: 5812611
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.